D89.42
Idiopathic mast cell activation syndrome
Clinical Classification Guidelines
Medical Intelligence & Overview
Idiopathic Mast Cell Activation Syndrome (MCAS) is a condition characterized by the abnormal activation and release of mast cells without a clear external trigger. Mast cells are a type of immune cell found throughout the body, especially in tissues like the skin, lungs, and digestive system. When activated inappropriately, they release chemical mediators such as histamine, which can cause a variety of symptoms. MCAS can be challenging to diagnose because its symptoms often overlap with other conditions, but understanding its features can help in managing the condition effectively.
Causes & Symptoms
Clinical Causes: The exact cause of idiopathic MCAS is unknown, hence the term 'idiopathic'. Genetic factors may play a role in susceptibility to abnormal mast cell activation. Potential triggers for mast cell activation in some cases include infections, stress, certain foods, or medications, though these are not the primary causes in idiopathic cases. Some individuals might have underlying genetic mutations affecting mast cell regulation, although these are not always identified.
Key Symptoms: Skin reactions such as flushing, hives, and itching Breathing difficulties including nasal congestion, wheezing, or shortness of breath Gastrointestinal symptoms like nausea, vomiting, diarrhea, or abdominal cramping Cardiovascular signs such as low blood pressure, dizziness, or fainting Swelling of tissues, including facial swelling or edema Episodes of rapid heartbeat (tachycardia) Feeling of generalized weakness or fatigue Anaphylaxis in severe cases, which is a life-threatening allergic reaction
Diagnostic & Treatment
Diagnosis Path: Diagnosing idiopathic MCAS involves a combination of clinical evaluation and laboratory tests. Healthcare providers may review medical history, conduct physical examinations, and order blood or urine tests to measure levels of mast cell mediators like tryptase, histamine, or prostaglandins during symptomatic episodes. Since symptoms can vary widely, diagnosis often requires evidence of recurrent episodes with symptoms corresponding to mast cell activation, in the absence of other identifiable causes.
Treatment Protocols: While there is no cure for idiopathic MCAS, management focuses on controlling symptoms and preventing episodes. Treatment strategies include:
Clinical Advice & FAQs
Billing Guidance
Is D89.42 a billable ICD-10 code?
Yes, D89.42 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.42?
Clinical documentation must specify the nature of Idiopathic mast cell activation syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference